Gene expressions associated with chemosensitivity in human hepatoma cells

Hepato-Gastroenterology

Volumn 54, Issue 74, 2007, Pages 489-492

  Hoshida, Yujin ^a   Moriyama, Masaru ^a   Otsuka, Motoyuki ^a   Kato, Naoya ^a   Taniguchi, Hiroyoshi ^a   Shiratori, Yasushi ^b   Seki, Naohiko ^c   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Anticancer drug; Chemosensitivity; Gene expression; Hepatoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; COMPLEMENTARY DNA; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GLYCOPROTEIN P; GYRASE INHIBITOR; ISOMERASE; MANGANESE SUPEROXIDE DISMUTASE; MITOMYCIN C; MITOXANTRONE; NIMUSTINE; TOPOISOMERASE 2 BETA; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG;

ARTICLE; CHEMOSENSITIVITY; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HEPATOMA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MEMBRANE TRANSPORT PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDE DISMUTASE; UP-REGULATION;

EID: 34248183395     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso M del C, Sala M, Bru C, Rodes J, Bruix J: Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29:62-67.
2. Simonetti RG, Liberati A, Angiolini C, Pagliaro L: Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol 1997; 8:117-136.
3. Chan ES-Y, Chow PK-H, Tai B-C, Machin D, Soo K-C: Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.
4. Feitelson MA, Sun B, Tufan NLS, Liu J, Pan J, Lian Z: Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002; 21:2593-604.
5. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO, Weinstein JN: A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000; 24:236-244.
6. Yoshikawa T, Nagasugi Y, Azuma T, Kato M, Sugano S, Hashimoto K, Masuho Y, et al: Isolation of novel mouse genes differently expressed in brain using cDNA microarray. Biochem Biophys Res Commun 2000; 275:532-537.
7. Murray GI, Paterson PJ, Weaver RJ, Ewen SW, Melvin WT, Burke MD: The expression of cytochrome P-450, epoxide hydrolase, and glutathione S-transferase in hepatocellular carcinoma. Cancer 1993; 71:36-43.
8. Moore MJ, Erlichman C: Pharmacology of anticancer drugs. In: Tannock IF, Hill RP (Eds.). The basic science of oncology. 3rd Edition: McGraw-Hill, 1998; pp. 370-391.
9. Tannock IF, Goldenberg GG: Drug resistance and experimental chemotherapy. In: Tannock IF, Hill RP (Eds.). The basic science of oncology. 3rd Edition: McGraw-Hill, 1998; pp. 392-419.
10. Kang Y, Greaves B, Perry RR: Effect of acute and chronic intermittent hypoxia on DNA topoisomerase II alpha expression and mitomycin C-induced DNA damage and cytotoxicity in human colon cancer cells. Biochem Pharmacol 1996; 52:669-676.
11. Cleveland JL, Kastan MB: A radical approach to treatment. Nature 2000; 407:309-311.
12. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W: Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000; 407:390-395.
13. Kuninaka S, Ichinose Y, Koja K, Toh Y: Suppression of manganese superoxide dismutase augments sensitivity to radiation, hyperthermia and doxorubicin in colon cancer cell lines by inducing apoptosis. Br J Cancer 2000; 83:928-934.
14. Li JJ, Oberley LW: Overxpression of manganese-containing superoxide dismutase confers resistance to the cytotoxicity of tumor necrosis factor alpha and/or hyperthermia. Cancer Res 1997; 57:1991-1998.
15. Oberley LW: Anticancer therapy by overexpression of superoxide dismutase. Antioxid Redox Signal 2001; 3:461-472.
16. Lage H, Perlitz C, Abele R, Tampe R, Dietel M, Schadendorf D, Sinha P: Enhanced expression of human ABC-transporter tap is associated with cellular resistance to mitoxantrone. FEBS Lett 2001; 503:179-184.